Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The firm offers anthelmintic, anti-osteoporotic, anti-arthritic, anti-ulcerants, antibiotics, aphrodisiac, anti-cough, and cold and allergy dermatological products. The company was founded by Hemendra N. Bhuta, Uttambhai Nandlal Bhuta and Harshad N. Bhuta on June 10, 1985, and is headquartered in Mumbai, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
801
Frequently Asked Questions
What is Market Cap of Jenburkt Pharmaceuticals Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Jenburkt Pharmaceuticals Ltd. market cap is 4.57B.
What is the 52-week high for Jenburkt Pharmaceuticals Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Jenburkt Pharmaceuticals Ltd. 52 week high is 1,069.90 as of September 03, 2026.
What is the 52-week low for Jenburkt Pharmaceuticals Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Jenburkt Pharmaceuticals Ltd. 52 week low is 1,010.00 as of September 03, 2026.
What is Jenburkt Pharmaceuticals Ltd. stock price today?
Jenburkt Pharmaceuticals Ltd. stock price today is 1,030.10.
What was Jenburkt Pharmaceuticals Ltd. stock price yesterday?
Jenburkt Pharmaceuticals Ltd. stock price yesterday was 1,044.00.
What is the PE ratio of Jenburkt Pharmaceuticals Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Jenburkt Pharmaceuticals Ltd.'s P/E ratio is 13.87.
What is the Price-to-Book ratio of Jenburkt Pharmaceuticals Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Jenburkt Pharmaceuticals Ltd. P/B ratio is 2.3104.
What is the 50-day moving average of Jenburkt Pharmaceuticals Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Jenburkt Pharmaceuticals Ltd. 50-day moving average is 1,043.66.
How many employees does Jenburkt Pharmaceuticals Ltd. have?